Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]

Quality of life and safety in novel therapies for prostate cancer

Prof Heather Payne, Prof Alicia Morgans and Prof Bertrand Tombal

Quality of life and safety in novel therapies for prostate cancer ( Prof Heather Payne, Prof Alicia Morgans and Prof Bertrand Tombal )

[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally...

Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain

[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally advanced or metastatic breast cancer ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )

Enzalutamide plus androgen deprivation therapy prolongs survival in men with...

Prof Andrew Armstrong - Duke University, Durham, USA

Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-sensitive prostate cancer ( Prof Andrew Armstrong - Duke University, Durham, USA )

Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve...

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve efficacy in ovarian, fallopian, peritoneal cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )

Drug combination shows promise in treatment-resistant advanced ovarian cancer

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

Drug combination shows promise in treatment-resistant advanced ovarian cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )

Assessment of guideline adherence in breast cancer management among oncologists...

Dr Bolanle Adegboyega - Lagos University Teaching Hospital, Lagos, Nigeria

Assessment of guideline adherence in breast cancer management among oncologists in Nigeria ( Dr Bolanle Adegboyega - Lagos University Teaching Hospital, Lagos, Nigeria )

Challenges in first line ALK+ NSCLC and emerging data on ALK TKIs

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK

Challenges in first line ALK+ NSCLC and emerging data on ALK TKIs ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )

Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal...

Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA

Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer ( Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA )

Adding abiraterone acetate plus prednisolone to standard therapy lengthens...

Prof Nick James - The Institute of Cancer Research, London, UK

Adding abiraterone acetate plus prednisolone to standard therapy lengthens survival in non-metastatic high-risk prostate cancer ( Prof Nick James - The Institute of Cancer Research, London, UK )

Welcome to APCCC 2021

Prof Silke Gillessen and Prof Aurelius Omlin

Welcome to APCCC 2021 ( Prof Silke Gillessen and Prof Aurelius Omlin )

ESMO 2021 Roundup

Dr Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2021 Roundup ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed...

Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway

$Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refractory multiple myeloma ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )$

More from ecancer